tradingkey.logo

Charles River Laboratories International Inc

CRL
查看详细走势图
189.210USD
+5.510+3.00%
收盘 02/06, 16:00美东报价延迟15分钟
9.31B总市值
亏损市盈率 TTM

Charles River Laboratories International Inc

189.210
+5.510+3.00%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+3.00%

5天

-10.11%

1月

-12.45%

6月

+25.86%

今年开始到现在

-5.15%

1年

+13.80%

查看详细走势图

操作建议

Charles River Laboratories International Inc当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名14/392位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价217.09。中期看,股价处于上升通道。近一个月,市场表现较差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Charles River Laboratories International Inc评分

相关信息

行业排名
14 / 392
全市场排名
100 / 4521
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Charles River Laboratories International Inc亮点

亮点风险
Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
行业龙头
公司营业收入处于行业前列,最新年度总收入4.05B美元
估值低估
公司最新PE估值-123.68,处于3年历史低位
机构加仓
最新机构持股52.25M股,环比增加0.05%
景顺投资公司持仓
明星投资者景顺投资公司持仓,最新持仓市值1.10M

分析师目标

根据 19 位分析师
买入
评级
217.091
目标均价
+18.18%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Charles River Laboratories International Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Charles River Laboratories International Inc简介

Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
公司代码CRL
公司Charles River Laboratories International Inc
CEOFoster (James C)
网址https://www.criver.com/
KeyAI